Project Optimus for Radiation Therapy–Drug Combinations: Moving Beyond the Maximum Tolerated Dose
Authors:
- Alastair GreystokeAlastair Greystoke
- Sarah BrownSBSarah Brown
- Anthony ChalmersACAnthony Chalmers
- Jamie A. DeanJDJamie A. Dean
- Eric DeutschEDEric Deutsch
- Magnus T. DillonMDMagnus T. Dillon
- Kevin FranksKFKevin Franks
- Martin D. ForsterMFMartin D. Forster
- Gerard G. HannaGHGerard G. Hanna
- Kevin HarringtonKHKevin Harrington
- Stephen HarrowSHStephen Harrow
- Crispin HileyCHCrispin Hiley
- 30 July 2026
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Abstract
No abstract availableFunding Information
- Cancer Research UK (C7893/A28990)
- Cancer Research UK (CTUQQR-Dec22/100002)
- Medical Research Council (UKRI1417)
- UCLH Biomedical Research Centre (NIHR203322)
- Manchester Biomedical Research Centre (NIHR203308)
This publication has 32 references indexed in Scilit:
- Integration of Immune Checkpoint Blockade With Radiation in Lung Cancer: Lessons From Recent TrialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2026
- Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtableeClinicalMedicine, 2024
- Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung CancerJournal of Thoracic Oncology, 2024
- Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug developmentCPT: Pharmacometrics & Systems Pharmacology, 2024
- Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022Annals of Oncology, 2022
- Overview and Lessons From the Preclinical Chemoradiotherapy Testing ConsortiumInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020ESMO Open, 2021
- CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapyEuropean Radiology, 2021
- Radiomic Analysis of CT Predicts Tumor Response in Human Lung Cancer with RadiotherapyJournal of Digital Imaging, 2020
- Traditional Phase 1 and 2 Studies in Thoracic Radiation Oncology Should Be AbandonedInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014